Company intelligence / Profile preview
Meribank Biotech Co., Ltd
Taipei City, Taipei City, Taiwanorpha.net ↗
- Ownership
- Private
- Employees
- ~142
- Development stage
- Other
01
Overview
Meribank provides commercial stem cell banking services including collection, processing, characterization, storage, and application of cord blood-, cord tissue-, placenta-, and peripheral blood-derived stem cells. The company also develops allogeneic umbilical cord mesenchymal stem cell manufacturing processes. Clinical results pertain mainly to the parent company's investigational therapies.
- Therapeutic areas
- Pulmonology
- Modalities
- Mesenchymal stem cells (MSCs)Hematopoietic stem cells
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Meribank Biotech Co., Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Meribank Biotech Co., Ltd.